are needed to guide individualized management of patients with HCV-related cirrhosis,
who are increasingly being treated with highly effective and safe direct-acting antivirals
To read this article in full you will need to make a payment
Increased risk for hepatocellular carcinoma persists up to 10 years after HCV eradication in patients with baseline cirrhosis or high FIB-4 scores.
Gastroenterology. 2019; 157: 1264-1278.e4
Sofosbuvir plus Ribavirin for treatment-naïve chronic HCV genotype 4 patients: real-life experience.
Hepatol Int. 2018; 12: 339-347
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
J Hepatol. 2020; 72: 472-480
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018; 68: 394-424
Toronto HCC risk index: a validated scoring system to predict 10-year risk of HCC in patients with cirrhosis.
J Hepatol. 2017 Aug 24; (pii: S0168-8278(17)32248-1)
Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection.
Hepatol Res. 2019; 49: 136-146
New scoring method to predict risk of hepatocellular carcinoma in patients with chronic hepatitis C after pegylated interferon and ribavirin therapy.
J Interferon Cytokine Res. 2020; 40: 82-91
Validation of the hepatocellular carcinoma early detection screening (HES) Algorithm in a cohort of veterans with cirrhosis.
Clin Gastroenterol Hepatol. 2019; 17: 1886-1893.e5
Lateral collinearity and misleading results in variance-based SEM: an illustration and recommendations.
J Assoc Inf Syst. 2012; 13: 546-580
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.
J Natl Cancer Inst. 2008; 100: 1432-1438
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: a prospective study.
J Viral Hepat. 2020 Feb 12; 0: 1-9https://doi.org/10.1111/jvh.13276
Published online: June 03, 2020
In Press Journal Pre-Proof
© 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Access this article on ScienceDirect